WVU Medicine a lead site for national clinical trial MORGANTOWN, W.Va. – Millions of obese Americans have achieved successful weight loss through use of glucagon-like peptide-1 agonists (GLP-1), a game-changing class of obesity medications. Results are often dramatic, but lost weight can be quickly regained if patients stop taking the drug. Researchers are now investigating a possible long-term solution Read More…
